SUPRAPUBIC CATHETER MARKET ANALYSIS

Suprapubic catheters are used in a wide range of surgical applications including urinary tract infections (UTIs), bladder stones, bladder cancer, and bypass track by urine. Furthermore, suprapubic catheterization is commonly used for postoperative bladder drainage after gynecologic procedures. Suprapubic catheters are also used for bladder drainage to manage short-term voiding dysfunction after pelvic surgery. Suprapubic catheterization refers to the placement of a drainage tube into the urinary bladder just above the pubic symphysis. This is typically performed for individuals who are unable to drain their bladder via the urethra. Suprapubic catheterization offers an alternative means to drain the urinary bladder when other methods are not clinically feasible, undesirable or impossible.

Global suprapubic catheter market is estimated to be valued at US$ 15,392.75 million in 2022 and is expected to exhibit a CAGR of 7.3% during the forecast period (2022-2030).

Figure 1. Global Suprapubic Catheter Market Share (%), by End User, 2022

To learn more about this report, request sample copy

Increasing product launches are expected to drive growth of the global suprapubic catheter market.

Increasing       launches of new products are expected to drive the global suprapubic market growth over the forecast period. For Instance, in March 2021, the U.K. firm's suprapubic catheter system launched by utilizing the Seldinger Technique. When compared to other Suprapubic Catheter Kits, the S-Cath System aims to provide a less traumatic approach yet provides similar drainage benefits of larger devices. Hence, S-Cath System is the standard of care in the UK and adopted by Texas radiologists.

Figure 2. Global Suprapubic Catheter Market Share (%), by Region, 2022

To learn more about this report, request sample copy

Rise in research & development activities for the development of suprapubic catheter are expected to drive the market growth during the forecast period.

Increasing research and development activities by key players in market for the development of suprapubic catheter are expected to drive the market growth over the forecast period. For instance, in March 2018, Mayo Clinic completed clinical study for silver-impregnated suprapubic catheters (SPC) in urogynecology. The study was conducted to show a statistically significant decrease in urinary tract infection (UTI) rate among the individuals with a silver-alloy suprapubic catheter compared to the standard silver-alloy catheter.

Global Suprapubic Catheter Market– Impact of Coronavirus (COVID-19) Pandemic

Since the COVID-19 virus outbreak in December 2019, the disease has spread to over 100 countries across the globe and the World Health Organization had declared it a public health emergency on January 30, 2020.

COVID-19 can affect the economy in three main ways: by directly affecting production and demand of drugs, by creating disruptions in distribution channels, and through its financial impact on firms and financial markets. Due to nationwide lockdowns, several countries, such as China, India, Saudi Arabia, U.A.E., Egypt, and others, are facing problems with regards to the transportation of drugs from one place to another.

However, the COVID-19 pandemic had a negative impact on the global suprapubic catheter market, owing to decrease in the surgical procedures which decreased the demand for suprapubic catheter. For instance, in March 2021, according to the data published by the Springer Nature, urogynaecological patients face particular challenges owing to inherent vulnerabilities of these populations. Behavioural and medical therapies should be recommended as first line options and initiated via virtual or remote clinics, which are integral to management during the COVID-19 pandemic.  During COVID-19 pandemic the surgical procedures were decreased for avoiding the spread of infection of coronavirus in the healthy volunteers.  At the procedure level, a decrease of 14.8% was observed for elective procedures and 6.0% for emergency procedures. COVID-19 infections in general surgical patients are rare (0.6% prevalence), but associated with high mortality (21.8%).

Global Suprapubic Catheter Market: Key Developments

In February 2020, Levity Products Incorporated, a medical device company, launched a set of newly patented and clinically proven external catheter stabilizers, a new medical device known as The LECS that is expected to revolutionize the catheter stabilization market.  In addition, Levity manufactures a one-of-its-kind suprapubic catheter stabilizer designed to drastically reduce infections, a well-recognized source of increased morbidity and economic burden in acute care services.

Global Suprapubic Catheter Market: Restraint

The major factors that hinder growth of the global suprapubic catheter market include complications associated with suprapubic catheters such as small bowel obstruction and bowel perforation during placement and exchange of catheter. Moreover, similar to Foley catheters, suprapubic catheters have mechanical complications such as infections, bladder spasms, obstruction, catheter encrustations, and retained catheters.

Key Players

Major players operating in the global suprapubic catheter market include Amecath, Becton, Dickinson and Company, B. Braun Melsungen AG, Cook Medical, Teleflex Incorporated, Fortune Medical Instrument Corp, Degania Silicone Ltd., Bard Medical, Urovision GmbH, UroTech Inc., and UroMed.